Advisory Board

JADO’s management is strongly supported by a hands-on advisory board with extensive and diverse experience in the pharmaceutical and biotechnology industry. Their extensive national and international networks provide important access for JADO in the biomedical, corporate and financing fields.

Dr. Joachim Rautter - Chairman Director, Investment Management PEPPERMINT. Financial Partners, Berlin Dr. Joachim Rautter is responsible for investment strategy and portfolio management of PEPPERMINT Venture Capital Fund. He has extensive experience with technology start-ups and financing tools and coaches more than 40 companies in the areas of bio-, micro- and nanotechnology. Dr. Rautter is a trained physicist and biophysical chemist who gained his PhD in 1995 from the Technical University of Berlin. Dr. Rautter advises JADO on financial engineering and strategic development.

 

Dr. Torsten Goesch Partner Bioscience Managers Ltd., Munich Dr. Goesch has a proven commercial track record in building high-growth biotechnology and pharmaceutical companies and is an experienced general manager in international business settings. From 1997-1999, he served as Central European General Manager for Biogen Inc. Previously, Dr. Goesch was Commercial Head for the worldwide generics drug business of Merck Generics. From 1988-1990, Dr. Goesch practiced as a medical doctor at the University Hospital Hamburg-Eppendorf, with a focus on nephrology, immunology and oncology. Dr. Goesch received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University, Chicago in 1992.

 

Dr. Ulrich Pessara Partner JSB-Partners, Munich Dr. Ulrich Pessara had a solid scientific career in molecular immunology for more than ten years. In 1991, he joined Boehringer Mannheim where he was responsible for biopharmaceutical drug development with several international biotech partners. He served as managing director and board member in several international joint venture biotech companies in San Diego, USA, Milan, Italy and Hanover, Germany. After 1997, he served as director of program management for international biotech alliances at Hofmann-La Roche. From 2000 to 2004, he was co-founder and COO of Xantos Biomedicine, a Munich based biotech company, where he was responsible for business development and strategic development. Dr. Pessara has broad experience in business and financial transactions in the pharmaceutical and biotech environment.

 

Dr. Jan Adams Partner EMBL Ventures, Heidelberg Dr. Jan Adams trained as a Biochemist at the University of Tübingen and completed his Ph.D. with work at the Wellcome/CRC Institute in Cambridge/UK. For his postdoctoral training he went to Granada/Spain to work in stem cell genetics. He joined EMBL Ventures in 2002 as an Investment Manager. In 2006, Dr. Adams was selected as class 11 fellow of the prestigious Kaufmann Program for Venture Education.

 

Dr. Aristotelis Nastos Investment Manager NRW Bank Dr. Nastos has held several positions within the German life science industry focusing on venture financing, most recently at the NRW BANK in Duesseldorf as Investment Manager. Previously he also worked at Peppermint Financial Partners in Berlin concentrating on investments in life sciences and nanotechnologies. His deep scientific background has allowed him the seamless transition from academia to industry and finance. With a Masters of Science in Biology from the Ruhr-University of Bochum and subsequent Research Fellowship at the Dept. for Cell Biology at the University of Essen (PhD) and a Post Doc at the Randal Institute of the King's College in London (UK) as an International Fellow of The Wellcome Trust, he was able to successfully take on the position of Head of the Research Group at the German Diabetes Institute in Düsseldorf.